Nice increase in accumulation and a bullish trend. I'm long on this one and patience is a virtue waiting on a news update about the status with the FDA concerning filing a BLA after their review of the PH3 results. Remember, the PH3 trial only failed by Histogenics standards and not by the FDA's standard. With approval from the FDA Histogenics will be the top dogs...
EDIT and CRSP
CRISPR-Cas9, -Cas11, -Cas12 genetic improvements for bio-pharma partnerships
The next big thing to improving and repairing defects in you RNA
Currently at Fibretracement 0.618 and in spot to move up or down, depending on big money theory...wahahah!
but there's enough small money to pull it down, just saying for disclosure.
